DBVT Q3 2024 Earnings — DBV Technologies S.A. Revenue & Financial Results | Market Cap Arena

DBVTDBV Technologies S.A.

$560M

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M

Gross Profit

$1M100.0% margin

Operating Income

-$30M-2829.1% margin

Net Income

-$30M-2839.7% margin

EPS (Diluted)

$-1.60

QoQ Revenue Growth

+Infinity%

Cash Flow

Operating Cash Flow

-$22M

Free Cash Flow

-$23M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$93M

Total Liabilities

$39M

Stockholders' Equity

$54M

Cash & Equivalents

$46M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$0	—
Gross Profit	$1M	-$455,635	+335.3%
Operating Income	-$30M	-$21M	-47.7%
Net Income	-$30M	-$17M	-82.8%